INSIGHTS ON GENOMIC AND MOLECULAR ALTERATIONS IN MULTIPLE MYELOMA AND THEIR INCORPORATION TOWARDS RISK-ADAPTED TREATMENT STRATEGY: CONCISE CLINICAL REVIEW

Insights on Genomic and Molecular Alterations in Multiple Myeloma and Their Incorporation towards Risk-Adapted Treatment Strategy: Concise Clinical Review

Although recent advances in novel treatment rbf2030 approaches and therapeutics have shifted the treatment landscape of multiple myeloma, it remains an incurable plasma cell malignancy.Growing knowledge of the genome and expressed genomic information characterizing the biologic behavior of multiple myeloma continues to accumulate.However, translati

read more